Cholesterol in Inflammation & Remyelination

When demyelination occurs an inflammatory response is activated. Accumulation of excess myelin debris triggers cholesterol crystal formation, and cholesterol deposits in the CNS can overwhelm phagocytes, resulting in impaired tissue regeneration. Here is the latest research on cholesterol synthesis in inflammation and remyelination.

August 24, 2021

Salsalate reduces atherosclerosis through AMPKβ1 in mice.

Molecular Metabolism
Emily A DayGregory R Steinberg
August 23, 2021

TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination.

The Journal of Experimental Medicine
Garyfallia GounaMikael Simons
August 21, 2021

Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammation.

Proceedings of the National Academy of Sciences of the United States of America
Catherine LarochelleFrauke Zipp
August 13, 2021
Preprint
Open Access

Neuronal cholesterol synthesis is essential for repair of chronically demyelinated lesions in mice

BioRxiv : the Preprint Server for Biology
S. BerghoffGesine Saher
August 13, 2021

Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol.

Proceedings of the National Academy of Sciences of the United States of America
Hao WangScott B Hansen
August 5, 2021
Open Access

TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination.

The Journal of Cell Biology
Wan Yun HoShuo-Chien Ling
July 28, 2021

Characterization of Citrus Pectin Oligosaccharides and Their Microbial Metabolites as Modulators of Immunometabolism on Macrophages.

Journal of Agricultural and Food Chemistry
Haijuan HuSiyi Pan
July 26, 2021

Di(2-ethylhexyl)phthalate exposure exacerbates metabolic disorders in diet-induced obese mice.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Jhih-Wei HsuTsui-Chun Tsou
June 19, 2021

EBI2 is expressed in glial cells in multiple sclerosis lesions, and its knock-out modulates remyelination in the cuprizone model.

The European Journal of Neuroscience
Ilona KlejborAleksandra Rutkowska
May 1, 2021
Review
Open Access

Disrupted Lipid Metabolism in Multiple Sclerosis: A Role for Liver X Receptors?

Frontiers in Endocrinology
Inés Pineda-TorraElizabeth C Jury

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/cholesterol-in-inflammation-remyelination/7a5e25c6-106f-45eb-8409-6f5797666f87